BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20807097)

  • 1. Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders.
    Montanari F; Bhagat G; Clark-Garvey S; Seshan V; Zain J; Diefenbach C; McCormick E; Crook M; Conroy M; O'Connor OA
    Leuk Lymphoma; 2010 Sep; 51(9):1761-4. PubMed ID: 20807097
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation.
    Novoa-Takara L; Perkins SL; Qi D; Shidham VB; Vesole DH; Hariharan S; Luo Y; Ewton A; Chang CC
    Am J Clin Pathol; 2005 Jan; 123(1):104-12. PubMed ID: 15762285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience.
    Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ
    Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
    González-Barca E; Domingo-Domenech E; Capote FJ; Gómez-Codina J; Salar A; Bailen A; Ribera JM; López A; Briones J; Muñoz A; Encuentra M; de Sevilla AF; ; ;
    Haematologica; 2007 Nov; 92(11):1489-94. PubMed ID: 18024397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
    Yoon SO; Yu E; Cho YM; Suh C; Kim KM; Han DJ; Lee SG; Huh J
    Clin Transplant; 2012; 26(1):67-73. PubMed ID: 21269330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The spectrum of lymphoproliferations and malignant lymphoma after organ transplant].
    Müller-Hermelink HK; Ott G; Kneitz B; Rüdiger T
    Verh Dtsch Ges Pathol; 2004; 88():63-8. PubMed ID: 16892535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell and NK-cell posttransplantation lymphoproliferative disorders.
    Swerdlow SH
    Am J Clin Pathol; 2007 Jun; 127(6):887-95. PubMed ID: 17509986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
    J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
    Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
    Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of monomorphic B-cell plasmacytoma post-transplant lymphoproliferative disorder in a patient with previous autologous stem cell transplant.
    Oon ML; Soon G; Poon LM; Wang S
    Pathology; 2019 Oct; 51(6):644-646. PubMed ID: 31470993
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors and scores in post-transplantation lymphoproliferative disorders after solid organ transplantation.
    Dierickx D; Delforge M; Verhoef G
    J Clin Oncol; 2010 Jul; 28(21):e366; author reply e367-8. PubMed ID: 20479392
    [No Abstract]   [Full Text] [Related]  

  • 16. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
    Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series.
    Montanari F; Radeski D; Seshan V; Alobeid B; Bhagat G; O'Connor OA
    Br J Haematol; 2015 Nov; 171(4):491-500. PubMed ID: 26250758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.